COCRYSTAL PHARMA, INC. Debt Instrument, Convertible, Conversion Ratio
COCRYSTAL PHARMA, INC. (COCP) reported Debt Instrument, Convertible, Conversion Ratio of 8.00% for the 1-month period ending 2018-05-31, per its 10-K filed 2020-03-27.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionRatio1 · last filed 2020-03-27
- 2018-05-31: Debt Instrument, Convertible, Conversion Ratio 1 month 8.00%.
| Period end | Debt Instrument, Convertible, Conversion Ratio 1 month |
|---|---|
| 2018-05-31 | 8.00% 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |